Radiation protectants: current status and future prospects.
about
γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current StatusVitamin E: tocopherols and tocotrienols as potential radiation countermeasuresMedical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patentsHigh-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones.THE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY.Polysaccharide isolated from Parmelia tinctorum ameliorates ionizing irradiation-induced damage in mice.Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis.Progenitors mobilized by gamma-tocotrienol as an effective radiation countermeasure.Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.Radiation countermeasure agents: an update (2011-2014)Personalized Radioproteomics: Identification of a Protein Biomarker Signature for Preemptive Rescue by Tocopherol Succinate in CD34(+) Irradiated Progenitor Cells Isolated from a Healthy Control Donor.Genistein protects against biomarkers of delayed lung sequelae in mice surviving high-dose total body irradiationHistory and development of radiation-protective agents.Modifying radiation damage.Animal models for acute radiation syndrome drug discovery.Mechanisms of cardiac radiation injury and potential preventive approaches.A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in larA review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures.Podophyllum hexandrum as a potential botanical supplement for the medical management of nuclear and radiological emergencies (NREs) and free radical-mediated ailments: leads from in vitro/in vivo radioprotective efficacy evaluation.Potent radioprotective effects of combined regimens of famotidine and vitamin C against radiation-induced micronuclei in mouse bone marrow erythrocytes.Radioprotective potential of melatonin against ⁶⁰Co γ-ray-induced testicular injury in male C57BL/6 micePodophyllum hexandrum-Mediated Survival Protection and Restoration of Other Cellular Injuries in Lethally Irradiated Mice.Radiation protection and mitigation potential of phenylbutyrate: delivered via oral administration.Synergistic radiation protective effect of purified Auricularia auricular-judae polysaccharide (AAP IV) with grape seed procyanidins.A Metabolomic and Lipidomic Serum Signature from Nonhuman Primates Administered with a Promising Radiation Countermeasure, Gamma-Tocotrienol.Alpha-tocopherol succinate-mobilized progenitors improve intestinal integrity after whole body irradiation.Radioprotection to small intestine of the mice against ionizing radiation by semiquinone glucoside derivative (SQGD) isolated from Bacillus sp. INM-1.
P2860
Q26751505-0B04129E-2309-40B2-A96C-4BE45ABB5677Q28290335-30A6A9E5-E899-475D-B728-4CDC5C1E6927Q28817576-17458A86-2134-4ECB-8EB7-1BD3927B7854Q30888166-5E1ED547-2AFF-4D3C-91E2-CE4F99A0552BQ33728050-65856103-4015-4BA9-8829-31391486ABCFQ33907062-0A36EFC6-9804-4BA4-B7C0-4F60B279C9E2Q34049808-98E8DFC8-8996-446E-BD1A-BCE0740F80E3Q34572191-7669DCA3-AEE0-4D51-B87B-B59DE38EB469Q35566671-5C1CEEBE-0186-474B-BFE4-4CAA19F2C13BQ35626587-91D41643-13AD-4341-8423-9DC88E3BFF47Q36802901-6D7B51B2-4955-4D37-AD3C-4B069D047BF2Q36953665-F466E3F0-2331-4491-ACAD-53AB8DEA40E9Q37532178-693C5840-643A-4325-83BA-39EA986236CDQ37768190-D21B71FF-CEE1-44A0-80BA-747412D469BDQ38394740-32998466-0C0F-4AF3-8EDB-D42428272B55Q38510734-5AE5908F-0278-45C0-A72A-87906E310024Q38665691-C5F1017B-64CF-4A9A-B95A-A72C85D74ED9Q39398444-20770214-4CFB-4B87-8BD0-FB268CDBD53DQ39897015-3408E0E9-077D-4AE1-AEA0-91FCE965FA21Q41507852-80924771-0992-4B3B-89C2-96D9DB18C206Q41992349-60FCB260-F85F-4B8C-8DB3-3E51FAD48755Q42087770-ECF8B698-13DF-41ED-8A32-3990B1CCB18DQ46330013-A247FCD8-ED7E-4225-BEFC-82C54149BDF0Q46798093-6A008539-51D5-4830-8A38-09C4601EDB3AQ48337702-206890CB-A408-46E4-B4DD-E52F79E41DC9Q53127699-64BC5FD8-6B22-4F42-8FE2-98DC3C6ABB86Q53152426-D5559E38-3B8D-44C1-BDFC-3883E030F05C
P2860
Radiation protectants: current status and future prospects.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Radiation protectants: current status and future prospects.
@en
type
label
Radiation protectants: current status and future prospects.
@en
prefLabel
Radiation protectants: current status and future prospects.
@en
P1433
P1476
Radiation protectants: current status and future prospects.
@en
P2093
Thomas M Seed
P304
P356
10.1097/01.HP.0000175153.19745.25
P577
2005-11-01T00:00:00Z